Jeff Wald

Jeff Wald has extensive experience in the field of clinical pharmacology and modeling. Jeff currently holds the role of Executive Director and Head of Clinical Pharmacology at Sage Therapeutics since October 2021. Prior to this, they worked as a Distinguished Scientist at the same company from August 2019 to October 2021.

Before joining Sage Therapeutics, Jeff Wald served as the Vice President of Clinical Pharmacology at qPharmetra from January 2018 to August 2019. Jeff also held the position of Principal Pharmacometric Consultant at the same company from March 2015 to January 2018.

Jeff Wald has a significant background in the pharmaceutical industry, having worked at GlaxoSmithKline as a Senior Director of Clinical Pharmacology Modeling and Simulation from June 2003 to March 2015.

Their early career includes experience at Pharsight, where they served as a Consultant and Head of Customer Support & Training from 1998 to 2003. Prior to that, they worked as a Clinical Pharmacologist at Quintiles from January 1995 to February 1998.

Jeff Wald began their career as a Post-Doc at Hoffmann-La Roche from 1993 to 1994.

Overall, Jeff Wald's work experience demonstrates their expertise and leadership in clinical pharmacology, particularly in roles related to modeling and simulation.

Jeff Wald received their Bachelor's degree in Pharmaceutics from the University at Buffalo, where they studied from 1984 to 1988. Following this, they pursued a Doctor of Philosophy (PhD) in Pharmaceutics at the same institution, completing their studies from 1988 to 1993. In addition to their formal education, Jeff acquired a certification in Narrative Portraiture: Foundations of Portraiture from LinkedIn in March 2021.